Fibrous dysplasia associated with increased breast cancer risk

September 14, 2017

(HealthDay)—Patients with fibrous dysplasia (FD) are at increased risk for breast cancer, according to a study published online Aug. 30 in the Journal of Bone and Mineral Research.

Bas C.J. Majoor, M.D., from the Leiden University Medical Center in the Netherlands, and colleagues used hospital records from 134 female FD patients in the Netherlands and 121 in the United States to evaluate the potential relationship between and FD.

The researchers found that 15 patients (six polyostotic and nine McCune-Albright syndrome) had cancer (87 percent thoracic localizations). Using the Dutch Pathology Registry, they validated a breast cancer incidence rate of 7.5 percent at a of 46 years (6.5 percent at 51 years). Compared with the Dutch general population, the breast cancer risk in the study participants was increased 3.4-fold; it was increased 13.2-fold in thoracic disease. The breast cancer incidence rate in the U.S. cohort was 4.5 percent at a median age of 36 years. Compared with the U.S. general population, the in study subjects was increased 3.9-fold; it was increased 5.7-fold in thoracic disease. Four breast cancer specimens were positive for the GNAS mutation (44 percent).

"Risk of breast cancer is increased at a younger age, particularly in polyostotic FD, suggesting that screening for breast cancer should be considered in this particular group at a younger age than currently advocated by national guidelines," the authors write.

Explore further: Endometrial ablation doesn't increase cancer risk

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Endometrial ablation doesn't increase cancer risk

August 14, 2017
(HealthDay)—For women in Finland, endometrial ablation is not associated with increased risk of endometrial or breast cancer, according to a study published in the September issue of Obstetrics & Gynecology.

Genetic predisposition to breast cancer due to non-brca mutations in ashkenazi Jewish women

July 20, 2017
Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in Ashkenazi Jewish women. A new article published by JAMA Oncology examines the likelihood of carrying another cancer-predisposing mutation ...

IVF treatment not associated with increased risk of breast cancer

July 19, 2016
Among women undergoing fertility treatment in the Netherlands between 1980 and 1995, the use of in vitro fertilization (IVF) compared with non-IVF treatment was not associated with increased risk of breast cancer after a ...

Mortality up with depression just before breast cancer diagnosis

April 14, 2017
(HealthDay)—Women with newly-developed depression before a breast cancer diagnosis have a modestly, but significantly, increased risk for death, according to a study published online April 7 in Cancer.

Early first cancer in BRCA1/2 ups risk in opposite breast

December 30, 2015
(HealthDay)—BRCA1/2 mutation carriers have increased risk of contralateral breast cancer (CBC), with age at first diagnosis a significant predictor of CBC risk, according to a study published online Dec. 23 in the Journal ...

Breast cancer patients with dense breast tissue more likely to develop contralateral disease

February 7, 2017
Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the contralateral breast, according to new research from The University of Texas MD Anderson Cancer.

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.